Cevimeline Capsule
Product Images NDC 69452-316

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cevimeline (NDC 69452-316). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bionpharma Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Principal Display Panel (30 mg Capsule Bottle Label)

Principal Display Panel (30 mg Capsule Bottle Label)
This text contains information about a medication with the NDC code 69452-316-20. Each capsule of the medication contains 30 mg of cevimeline hydrochloride. The package insert provides information about the dosage and administration of the medication. It is recommended to store the medication at a temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F) according to USP Controlled Room Temperature guidelines. The medication should be dispensed in tight containers. It is important to keep this medication and all drugs out of the reach of children. The medication is distributed by Bionpharma Inc. with an address in Princeton, NJ 08540. The medication is made in India. The text also includes a code and indicates that it is for prescription use and includes 100 capsules.*
FDA Label Image

Structural Formula (Structure01)

Structural Formula (Structure01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.